Suppr超能文献

p53 依赖性对 Polo 样激酶-1(PLK1)的抑制。

p53-dependent repression of polo-like kinase-1 (PLK1).

机构信息

Biomedical Research Institute, University of Dundee, Dundee, UK.

出版信息

Cell Cycle. 2010 Oct 15;9(20):4200-12. doi: 10.4161/cc.9.20.13532. Epub 2010 Oct 4.

Abstract

PLK1 is a critical mediator of G₂/M cell cycle transition that is inactivated and depleted as part of the DNA damage-induced G₂/M checkpoint. Here we show that downregulation of PLK1 expression occurs through a transcriptional repression mechanism and that p53 is both necessary and sufficient to mediate this effect. Repression of PLK1 by p53 occurs independently of p21 and of arrest at G₁/S where PLK1 levels are normally repressed in a cell cycle-dependent manner through a CDE/CHR element. Chromatin immunoprecipitation analysis indicates that p53 is present on the PLK1 promoter at two distinct sites termed p53RE1 and p53RE2. Recruitment of p53 to p53RE2, but not to p53RE1, is stimulated in response to DNA damage and/or p53 activation and is coincident with repression-associated changes in the chromatin. Downregulation of PLK1 expression by p53 is relieved by the histone deacetylase inhibitor, trichostatin A, and involves recruitment of histone deacetylase to the vicinity of p53RE2, further supporting a transcriptional repression mechanism. Additionally, wild type, but not mutant, p53 represses expression of the PLK1 promoter when fused upstream of a reporter gene. Silencing of PLK1 expression by RNAi interferes with cell cycle progression consistent with a role in the p53-mediated checkpoint. These data establish PLK1 as a direct transcriptional target of p53, independently of p21, that is required for efficient G₂/M arrest.

摘要

PLK1 是 G₂/M 细胞周期转换的关键介质,作为 DNA 损伤诱导的 G₂/M 检查点的一部分被失活和耗尽。在这里,我们表明 PLK1 表达的下调是通过转录抑制机制发生的,p53 是介导这种效应所必需的和充分的。p53 通过独立于 p21 的机制抑制 PLK1 的表达,并且独立于 G₁/S 的阻滞,在细胞周期依赖性方式中,PLK1 水平通常通过 CDE/CHR 元件在 G₁/S 被抑制。染色质免疫沉淀分析表明,p53 存在于 PLK1 启动子上的两个不同位点,称为 p53RE1 和 p53RE2。p53 与 p53RE2 的募集,但不与 p53RE1 的募集,在 DNA 损伤和/或 p53 激活时受到刺激,并且与染色质中与抑制相关的变化一致。p53 通过组蛋白去乙酰化酶抑制剂曲古抑菌素 A 缓解 PLK1 表达的下调,并且涉及组蛋白去乙酰化酶向 p53RE2 附近的募集,进一步支持转录抑制机制。此外,野生型,但不是突变型,p53 抑制与报告基因融合的 PLK1 启动子的表达。RNAi 沉默 PLK1 表达会干扰细胞周期进程,这与 p53 介导的检查点中的作用一致。这些数据将 PLK1 确立为 p53 的直接转录靶标,独立于 p21,是有效 G₂/M 阻滞所必需的。

相似文献

1
p53-dependent repression of polo-like kinase-1 (PLK1).
Cell Cycle. 2010 Oct 15;9(20):4200-12. doi: 10.4161/cc.9.20.13532. Epub 2010 Oct 4.
4
Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).
Cell Cycle. 2009 Feb 1;8(3):460-72. doi: 10.4161/cc.8.3.7651. Epub 2009 Feb 18.
5
Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Cell Signal. 2011 Nov;23(11):1816-23. doi: 10.1016/j.cellsig.2011.06.016. Epub 2011 Jun 29.
6
Nitric oxide down-regulates polo-like kinase 1 through a proximal promoter cell cycle gene homology region.
J Biol Chem. 2007 Jan 12;282(2):1003-9. doi: 10.1074/jbc.M607609200. Epub 2006 Nov 22.
7
p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
Exp Cell Res. 2013 Dec 10;319(20):3104-15. doi: 10.1016/j.yexcr.2013.09.012. Epub 2013 Sep 26.
8
Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Oncol Rep. 2015 Mar;33(3):1235-42. doi: 10.3892/or.2015.3723. Epub 2015 Jan 15.
10
Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability.
Mol Cancer Ther. 2010 Jul;9(7):2079-89. doi: 10.1158/1535-7163.MCT-10-0095. Epub 2010 Jun 22.

引用本文的文献

1
The status of p53 affects the efficacy of PLK1 inhibitor BI6727 in prostate cancer cells.
Front Cell Dev Biol. 2025 Jul 30;13:1602693. doi: 10.3389/fcell.2025.1602693. eCollection 2025.
6
The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma.
Transl Oncol. 2022 Aug;22:101448. doi: 10.1016/j.tranon.2022.101448. Epub 2022 Jun 1.
7
Structure-activity and mechanistic studies of non-peptidic inhibitors of the PLK1 polo box domain identified through REPLACE.
Eur J Med Chem. 2022 Jan 5;227:113926. doi: 10.1016/j.ejmech.2021.113926. Epub 2021 Oct 21.
9
Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells.
Cell Death Differ. 2022 Feb;29(2):407-419. doi: 10.1038/s41418-021-00864-2. Epub 2021 Sep 24.
10
The complexity of p53-mediated metabolic regulation in tumor suppression.
Semin Cancer Biol. 2022 Oct;85:4-32. doi: 10.1016/j.semcancer.2021.03.010. Epub 2021 Mar 27.

本文引用的文献

1
Tumor suppressive functions of p53.
Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a001883. doi: 10.1101/cshperspect.a001883.
2
The first 30 years of p53: growing ever more complex.
Nat Rev Cancer. 2009 Oct;9(10):749-58. doi: 10.1038/nrc2723.
3
Blinded by the Light: The Growing Complexity of p53.
Cell. 2009 May 1;137(3):413-31. doi: 10.1016/j.cell.2009.04.037.
4
Polo-like kinases: conservation and divergence in their functions and regulation.
Nat Rev Mol Cell Biol. 2009 Apr;10(4):265-75. doi: 10.1038/nrm2653.
5
Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation.
Mol Cell Biol. 2009 May;29(10):2609-21. doi: 10.1128/MCB.01277-08. Epub 2009 Mar 16.
6
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53.
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3964-9. doi: 10.1073/pnas.0813333106. Epub 2009 Feb 18.
7
Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).
Cell Cycle. 2009 Feb 1;8(3):460-72. doi: 10.4161/cc.8.3.7651. Epub 2009 Feb 18.
8
Transcriptional control of human p53-regulated genes.
Nat Rev Mol Cell Biol. 2008 May;9(5):402-12. doi: 10.1038/nrm2395.
9
p53 in health and disease.
Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83. doi: 10.1038/nrm2147.
10
Polo-like kinase 1: target and regulator of transcriptional control.
Cell Cycle. 2006 Dec;5(24):2881-5. doi: 10.4161/cc.5.24.3538. Epub 2006 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验